The Bristol-Myers Squibb 2018 Golden Ticket Program (“Program”) is a competition for the award of two Golden Tickets.
A Golden Ticket is one year of underwritten lab bench space at LabCentral (Cambridge, MA), including all resident benefits, for a promising life science start-up. The Program will award a total of two Golden Tickets in 2018 to the one or two companies that best meet the judging criteria of the Program including that they are engaged in therapeutic research in the fields of Oncology, Immunology, Cardiovascular, or Fibrosis, and/or are companies pursuing research in novel target identification, drug delivery, discovery technology platforms, or translational R&D.
LabCentral provides fully equipped, permitted, and supported lab space for biomedical research, plus programming and unmatched networking opportunities to help start-ups advance their science and build their companies. Visit: http://labcentral.org/facilities-services/ to learn more.
Applications for the Program are being accepted through July 6, 2018.